Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
Brief Summary:
This research study is studying the use of a targeted therapy called LY SARM, which is an investigational drug from a new class of molecules called Selective Androgen Receptor Modulators (SARMs) as a possible improvement in quality of life for participants who have undergone radical prostatectomy. Androgens are a group of hormones that play a role in male traits and reproductive activity.
The names of the study interventions involved in this study are:
- LY2452473